A comparative cost analysis of newborn screening for classic congenital adrenal hyperplasia in Texas

Public Health Reports

Volumn 113, Issue 2, 1998, Pages 170-178

  Brosnan, Christine A ^a   Brosnan, Patrick ^b,c   Therrell, Bradford L ^d   Slater, Carl H ^c,e   Swint, J Michael ^c,e   Annegers, John F ^c,e   Riley, William J ^b,c  

^a UNIVERSITY OF TEXAS   (United States)

^b Baylor College of Medicin

^c Department of Pediatrics ^*

^d TEXAS DEPARTMENT OF STATE HEALTH SERVICES   (United States)

^e UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYPROGESTERONE;

ARTICLE; BLOOD SAMPLING; COMPARATIVE STUDY; CONGENITAL ADRENAL HYPERPLASIA; COST BENEFIT ANALYSIS; HUMAN; MAJOR CLINICAL STUDY; NEWBORN; NEWBORN SCREENING; PRIORITY JOURNAL; UNITED STATES;

EID: 0031981790     PISSN: 00333549     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Barden HS, Kessell R. The costs and benefits of screening for congenital hypothyroidism in Wisconsin. Soc Biol 1984;31:185-200.
2. Barden HS, Kessel R, Schuett VE. The costs and benefits of screening for PKU in Wisconsin. Soc Biol 1984;31:1-17.
3. National screening status report. Infant Screening (Therrell BL, editor. Austin, TX: ISSN 0886-315) 1997;20(1):7.
4. Office of Technology Assessment (US). Healthy children: investing in the future. Washington: OTA; 1988. Pub. No.: PB88-178454.
5. Gessner BD, Teutsch SM, Shaffer PA. A cost-effectiveness evaluation of newborn hemoglobinopathy screening from the perspective of state health care systems. Early Human Development 1996;45:257-75.
6. Owerbach D, Crawford YM, Draznin MB. Direct analysis of CYP21B genes in 21-hydroxylase deficiency using polymerase chain reaction amplification. Mol Endocrinol 1990;4:125-31.
7. Migeon CJ, Donohoue P. Adrenal disorders. In: Kappy MS, Blizzard RM, Migeon CJ, editors. Diagnosis and treatment of endocrine disorders in childhood and adolescence. 4th ed. Springfield (IL): Charles C. Thomas; 1994. p. 717-856.
8. New MI, White PC, Pang S, Dupont B, Speiser PW. The adrenal hyperplasias. In: Scriver CR, Beaudet AL, Sly WI, Valle D, editors. The metabolic basis of inherited disease. 6th ed. New York: McGraw-Hill; 1989. p.1881-1917.
9. Donohoue PA, Parker K, Migeon CJ. Congenital adrenal hyperplasia. In: Scriver CR, Beaudet AL, Sly WS, Valle D, editors. The metabolic and molecular basis of inherited disease. 7th ed. New York: McGraw-Hill; 1995.p. 2929-66.
10. Pang S, Clark A. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency: newborn screening and its relationship to the diagnosis and treatment of the disorder. Screening 1993;2:105-39.
11. Pang S, Hotchkiss J, Drash AL, Levine LS, New MI. Microfilter paper method for 17a-progesterone radioimmunoassay: its application for rapid screening for congenital adrenal hyperplasia. J Clin Endocrinol Metab 1977;45:1003-8.
12. New MI, Gertner JM, Speiser PW, Del Balzo P. Growth and final height in classical and nonclassical 21-hydroxylase deficiency. J Endocrinol Invest 1989; 12 Suppl 3: 91-5.
13. Aldis B, Therrell BL, Brown L. Addition of CAH screening to the Texas Department of Health newborn screening program. In: Bradford H, Hannon W, Therrell BL, editors. Proceedings of the Seventh National Neonatal Screening Symposium; 1989 Nov 15-19; New Orleans, LA. McLean (VA): Association of State and Territorial Public Health Laboratory Directors; 1990. p. 184-8.
14. Larsson A, Thilen A, Hagenfeldt L, von Dobeln U, Guthenberg C. Screening of half a million Swedish newborn infants for congenital adrenal hyperplasia. Screening 1992;1:159-66.
15. Cutfield WS, Webster D. Newborn screening for congenital adrenal hyperplasia in New Zealand. J Pediatr 1995;126:118-21.
16. Balsamo A, Cacciari E, Piazzi S, Cassio A, Bozza D, Pirazzoli P, et al. Congenital adrenal hyperplasia: neonatal mass screening compared with clinical diagnosis only in the Emilia-Romagna region of Italy, 1980-1995. Pediatrics 1996;98:362-7.
17. Allen DB, Hoffman GL, Fitzpatrick P, Laessig R, Maby S, Slyper A. Improved precision of newborn screening for congenital adrenal hyperplasia using weight-adjusted criteria for 17-hydroxyprogesterone levels. J Pediatr 1997;130:128-33.
18. Rothman KJ. Modern epidemiology. Boston: Little, Brown; 1986.
19. Rosner B. Fundamentals of biostatistics. Boston: PWS-Kent; 1990.
20. Therrell BL, Berenbaum SA, Gonzalez J, Manter-Kapanke V, Simmank, J, Korman K, et al. Results of screening 1.9 million Texas newborns for congenital adrenal hyperplasia. Pediatrics. In press 1997.
21. Drummond MF, Stoddart GL, Torrance GW. Methods for the economic evaluation of health care programmes. Oxford: Oxford University Press; 1987.
22. Finkler SA. The distinction between cost and charges. Ann Intern Med 1982;96:102-9.
23. Gold MR, Siegel JE, Russell LB, Weinstein MC. Cost-effectiveness in health and medicine. New York: Oxford University Press; 1996.
24. Briggs A, Sculpher M, Buxton M. Uncertainty in the economic evaluation of health care technologies: the role of sensitivity analysis. Health Econ 1994;3:95-104.
25. Health Resources and Services Administration (US). The registered nurse population. Washington: HRSA; 1992.
26. National Heritage Insurance Company. Texas Medicaid reimbursement methodology. Austin: Texas Department of Health; 1994.
27. Sorenson JR, Levy HL, Mangione TW, Sepe SJ. Parental response to repeat testing of infants with "false positive" results in a newborn screening program. Pediatrics 1984;73:183-7.
28. Tluczek A, Mischler EH, Farrell PM, Fost N, Peterson NM, Carey P, et al. Parents' knowledge of neonatal screening and response to false-positive cystic fibrosis testing. J Dev Behav Pediatr 1992;13:181-6.
29. Larsson A, von Dobeln U, Guthenberg C, Hagenfeldt L, Thilen A. Congenital adrenal hyperplasia - unsolved questions in neonatal screening. In: Farriaux JP, Dhondt JL, editors. New horizons in neonatal screening. New York: Elsevier Science BV; 1994. p. 155-60.
30. Therrell BL, Berenbaum SA. Difficulties in CAH diagnosis associated with newborn screening. In: Farriaux JP, Dhondt JL, editors. New horizons in neonatal screening. New York: Elsevier Science BV; 1994:169-72.